Category Archives: Government/Research

What the Reclassification of Marijuana Means for You

“Justice Department Places FDA-Approved Marijuana Products and Products Containing Marijuana Subject to a Qualifying State-issued License in Schedule III, Strengthening Medical Research While Maintaining Strict Federal Controls.” This headline, which appeared on the Department of Justice’s official website on April 23, 2026, refers to the Executive Order signed by President Trump.

Advocates and politicians have pushed for this change for years, arguing cannabis carries undeniable medical value. As of April 2026, medical marijuana use is legal in 40 states. Following many years of federal research that confirmed the potential benefits of marijuana use for medical conditions, this Executive Order reclassifies state-licensed medical marijuana from Schedule I, the most restrictive federal drug category, to the less regulated Schedule III. Acting Attorney General Todd Blanche stated the decision, “allows for research on the safety and efficacy of this substance, ultimately providing patients with better care and doctors with more reliable information.”

For brain injury survivors, the implications may be significant. One study, available on PubMed, found that patients with acquired brain injury have reported improvement in mood, anxiety, headache, sleep, and quality of life through medical cannabis use. Government-funded research also indicates that the non-psychoactive cannabis compound CBD, and THC, the primary psychoactive compound in cannabis that is responsible for the “high”, may be effective for pain management, anxiety, and insomnia, all of which are common symptoms following brain injury. (These benefits are debatable. Another major analysis found that medicinal cannabis does not effectively treat anxiety, depression, or PTSD, and may even worsen mental health in some cases.)

As always, caution is warranted. The CDC has proven that cannabis use affects brain development. Beyond brain development, a 2024 CDC report states, “cannabis use directly affects brain function — specifically the parts of the brain responsible for memory, learning, attention, decision-making, coordination, emotions, and reaction time.” Chronic marijuana consumption may reduce dopamine responsivity, increase negative emotionality, and induce anhedonia, meaning a reduced ability to experience pleasure or a loss of interest in previously enjoyed activities. These possible negative consequences are a significant concern for survivors, who already have cognitive issues and may struggle with low motivation.

While this rescheduling opens the door to better science, always consult a physician before using cannabis.

PEGASUS Takes Flight for Kids with Brain Injuries

Winged horse merged with a glowing brain and neural patterns against a cosmic background

When a child arrives at an ICU with severe traumatic brain injury, every minute counts and every decision matters. That’s exactly the problem the Pediatric Guideline Adherence and Outcomes (PEGASUS) program was built to solve.

Developed in 2011 at the Harborview Medical Center, a Level I Trauma Center affiliated with the University of Washington School of Medicine, PEGASUS was created to close the so-called “know-do” gap, translating Brain Trauma Foundation guidelines into bedside practice. The program trains key staff, redesigns workflows, and provides ongoing coaching.

Published in Critical Care Medicine on March 27, 2026, a new study shows the model can reach far beyond Seattle. Across 16 hospitals in Argentina, Chile, and Paraguay, children with isolated severe traumatic brain injury at PEGASUS hospitals showed 8 percentage points higher guideline adherence than those receiving standard care. This determination came from the first randomized trial of an implementation science approach to improving care in adult or pediatric traumatic brain injury.

The reach of PEGASUS is backed by federal investment: the study was supported by a grant from the U.S. National Institute of Neurological Disorders and Stroke. As Dr. Monica Vavilala of UW Medicine clarified, this approach can be adopted by hospitals around the world, whether or not they are Level I Trauma Centers.

Federal Government Joins States in Psychedelic Exploration

This morning, April 18, 2026, the federal government joined many states by committing to exploration of a brain injury treatment – “President Trump on Saturday signed an executive order to expedite research into the psychedelic ibogaine – a drug championed by podcaster Joe Rogan – so it can be used to treat PTSD in veterans and traumatic brain injuries,” reported the New York Post.

Heavily championed by the Secretary of Health and Human Services Robert F. Kennedy, ibogaine has recently been gaining a reputation for its treatment possibilities. Last month, March 1, 2026, the New York Times reported on one man’s treatment story. Due to federal limitations, he had to visit Mexico to be treated with  ibogaine. (In the United States, clinical studies began at Stanford University in 2022. Results have strongly suggested that ibogaine is effective in treating traumatic brain injury.)

Generation Alpha’s Trending Trauma

Speaker presenting to attentive diverse audience about online safety and 'Blackout Challenge' risks and prevention

In February 2026, nine-year-old JackLynn Blackwell died in her Stephenville, Texas backyard with a cord around her neck after seeing the “blackout challenge” online. A repackaging of the “choking game” that was first catalogued by the CDC in 2008, the blackout challenge is causing yourself to pass out. (This, in turn, causes “permanent, irreversible brain damage”.) It exploded on TikTok in 2021, as the For You algorithm began pushing self-strangulation videos to young users chasing a brief euphoric high from cerebral hypoxia. The trend has shown its lasting power: In South Orange Middle School in New Jersey, two students passed out after engaging in the challenge in 2024.

The blackout challenge has been noticed by politicians: on October 8, 2024, a bipartisan coalition of 14 attorney generals filed separate enforcement actions. “TikTok claims that their platform is safe for young people … [but] young people have died or gotten injured doing dangerous TikTok challenges,” remarked the group’s co-leader Letitia James (NY). In a March 23, 2026 press release, Congressman Jimmy Patronis (FL) stated, “As a parent, I cannot ignore the very real danger [the blackout challenge] poses to our children. Too many families have already suffered unimaginable loss.”  

Beyond concern, this childhood “thrill-seeking” has prompted some schools to take action. In New York, New Jersey and other states, schools have issued parental advisories in an attempt to protect children’s developmentally immature brains. One can hope that this trend is waning in popularity, and will soon be remembered only as an unfortunate episode in Generation Alpha’s past.

GLP-1 Drugs Surprising Neuroprotective Qualities

Diagram of GLP-1 (7-36) amide peptide showing amino acid sequence, side chains, chemical formulas, and α-helix structure

The weight-loss drug semaglutide, sold under the names Ozempic and Wegovy, may do far more than shrink waistlines. Research suggests it could also shield the brain after traumatic injury.

A 2026 study published in Neural Regeneration Research by scientists at Beijing Tiantan Hospital, and available in the PubMed database, found that semaglutide reduced brain swelling, preserved the blood-brain barrier, and blocked dangerous inflammatory cascades in mice with traumatic brain injuries. “Our findings reveal the dual anti-inflammatory and neuroprotective roles of semaglutide, providing important preclinical evidence for its clinical application in the acute phase of traumatic brain injury,” the researchers wrote.

The possibilities are enormous. Last year, a University of Wisconsin–Madison retrospective study of more than two million stroke patients found that those taking semaglutide had a mortality rate of just 5.26%, compared with 21.61% for non-users.

While human clinical trials for TBI are still needed, scientists say GLP-1 drugs represent the most promising new avenue for brain injury treatment in decades.

Study Bolsters Push for Personalized Treatment

Poster with the text 'Every Brain Injury is Different' overlaid on abstract neural network graphics

A study published in the journal Neurology (epub April 3, 2026; print April 28, 2026), and currently available through the NLM PubMed database, reveals evidence that traumatic brain injuries affect each person’s brain in remarkably unique ways. While such a scientific revelation may seem evident to survivors, it challenges one-size-fits-all treatment approaches.

Researchers led by Jake Mitchell of Monash University (Australia) analyzed brain scans from 407 TBI patients and 224 healthy controls using normative modeling, a technique that measures individual brains against healthy population norms much like pediatric growth charts.  Co -authored by researchers at the VA Palo Alto Healthcare System, the study found that no more than 23% of patients shared an extreme deviation in the same brain region.

The findings help explain why nearly 30 clinical trials for acute TBI treatments have failed to identify effective therapies. The study results also bolster the case for personalized brain injury medicine. 

Mississippi Joins States for Psychedelic Experimentation

A neon-lit chemical molecular structure floating in a colorful cosmic nebula with stars and galaxies.

Mississippi is now following Texas and a handful of other states, by positioning itself on the frontier of a potential neurological revolution. On March 19, 2026, Mississippi Governor Tate Reeves made history by signing HB 314 into law, authorizing the Mississippi State Department of Health to use $5 million of Mississippi’s opioid settlement money to fund clinical trials for the drug ibogaine. The bill takes effect July 1 and allows Mississippi to coordinate trials with other states, including Texas, which has already committed to its own program.

A psychoactive substance derived from the root of a plant native to Africa, ibogaine has been used for centuries in spiritual and healing ceremonies. More recently, it has gained scientific interest for its potential to treat opioid and cocaine addiction. Research suggests it increases signaling of important brain molecules linked to drug addiction and depression. Currently a Schedule I controlled substance, Americans seeking treatment must travel abroad at costs that reportedly reach up to $50,000 per session.

As stated by Dr. Nolan Williams, who was involved in the landmark 2024 Stanford University study that brought attention to the use of ibogaine for brain injury, “no other drug has ever been able to alleviate the functional and neuropsychiatric symptoms of traumatic brain injury.”

Brain Booster in Easter Basket & Candy Aisle Year-round

Wicker basket filled with chocolate peanut butter cups and colorful pastel candy eggs.

This Easter, as you unwrap a peanut butter egg, you may be doing your mind a bigger favor than you realize.

Peanut butter is a quiet powerhouse for cognitive health, loaded with niacin (B3) and vitamin E. Though peanuts may be in the legume family, rather than a nut, its brain benefits fall in line with them. A recent and compelling study, published in November 2025 by Clinical Nutrition, and accessible through PubMed, is a randomized crossover trial that gave 31 healthy older adults 60g/day of skin-roasted peanuts for 16 weeks. Using MRI scans as a guide, the authors concluded: “Daily consumption of skin-roasted peanuts for 16 weeks improved brain vascular function in healthy older men and women. These favorable effects may underlie the observed improvements in verbal memory.”

Dark chocolate truffle with a bite taken out revealing a creamy peanut butter center.

The implications run deeper than better recall, as studies have long proven. A 2024 review, prepared under a Defense Health Agency contract, found that, “preclinical studies and early human trials suggest that specific nutrients and diets may offer neuroprotection or benefit during mild TBI rehabilitation.” Peanut butter’s niacin is among the compounds flagged by PubMed research as exhibiting neuroprotective properties by reducing lesion volume, oxidative stress, and neuronal damage after TBI.

The brain benefits of dark chocolate have also been widely proven. So, year-round, if you’re browsing the candy aisle, try looking for dark chocolate peanut butter cups for a brain boost.  

Your Eyes Can Reveal What’s In Your Brain

In March 2026, the University of Colorado Anschutz Medical Campus published the results of a study that reveals high-speed eye-tracking technology can detect lasting neurological damage from mild traumatic brain injuries. More so, it showed that the damage that can be detected may be completely invisible to MRI scans, CT imaging, and routine clinical exams. This matters enormously. Current standard concussion assessments are largely subjective and can result in patients being told they’ve recovered when their brains are still struggling.

At the CU’s Marcus Institute for Brain Health, researchers tested 78 military veterans and measured subtle disruptions in eye movement that expose hidden neural damage. The findings were sobering: deficits persisted 10 to 15 years after the original injury. As Dr. Jeffrey Hebert, who led the study, noted, “Even when someone feels recovered, their brain may still be working differently behind the scenes.” Funded by the Department of Defense, this technology offers something conventional medicine currently cannot – objective, documented proof of brain trauma.

Man’s Best Friend Aids Brain Injury Recovery

Dogs are proving to be powerful partners in brain injury rehabilitation, offering benefits across physical, emotional, and speech therapy alike.

A March 2026 story from the University of Colorado Health (UCHealth) system documented Alan Tay, a 71-year-old stroke survivor who credits his border collie Olay with driving his recovery. Working with a neurological physical therapist, Alan used dog agility training to rebuild endurance, coordination, and memory – ultimately winning a national canine competition just three months after his stroke. Emotionally, dogs combat the depression and isolation that frequently accompany brain injury. The above-mentioned UCHealth story also notes that Olay gave Alan the will to push through. An NIH-funded clinical trial confirmed that service dogs may meaningfully reduce PTSD symptoms in military members and veterans.

Dogs can assist with speech recovery, as well. Research shows that aphasia patients produce more verbal and nonverbal communication around therapy dogs, which respond to tone and gesture rather than specific words. Speech therapy in such a uniquely low-pressure and therapeutic environment is highly beneficial for language practice.

The bipartisan SAVES Act, which reached the Senate calendar in February 2026, would fund service dogs for veterans with TBI and PTSD. Introduced by Rep. Morgan Luttrell (TX) on April 2, 2025, H.R.2605 explicitly lists “Traumatic brain injury” as a covered condition, recognizing that a trained service dog can be “optimal for the veteran to manage the disability, condition, or diagnosis and live independently.” In March 2026, America’s VetDogs launched a national campaign during this Brain Injury Awareness Month that highlights service dogs’ life-changing impact for TBI survivors, particularly as it relates to counter-balance support and deep pressure therapy.